Member Info for Prion25

Also they got their eyes on 100,000 's of treatments to supplement their loss . The race is on ?

15K gulp! might more now too scared to look !

Van Tan on 24hr News talking - there is some data on the reduction of transmission and is optimistic that vaccine proved effective but reserves judgement till he see all of the data

Win
I meant only prevents hospitalisation (but no mention of prevention of transmission which is equally important in ending the pandemic )

Oxford have not mentioned whether vac prevents transmission only says it prevents hospitalisation which seems to be remarkable when most of the UK pop who are infected without vac do not need hospitalisation. But RM needs to start blowing his trumpet or bugle more like get some decent PR like the Guardian cannot wait till March .I thought Nov was going to be Newsvember !

a course of treatment not package

Does the £38 cost refer to asthma and COPD outdated price ?Hospitalised Covid 19 patients will require " a Treatment "package" I am guessing

Does the Guardian read this bulletin board all the mention of mutation and AZ and importance of therapeutics all mentioned here yesterday morning with some brilliant posts nevertheless PR desperately welcome thanks to the Guardian

Stockpiling is a key and a sensible strategy in future pandemics I worked in defra and a lot of time was prioritising disease outbreak planning and monitoring for viruses such as bird flu ,swine fever and host of others .All have devastating economic consequences and mega culling of animals ,moreover there was always anxiety of HIN1 strains and mutants spilling over into the the human population with no vaccine available having similar consequences to Spanish flu . Coronavirus is not the only threat, further zoonotic respiratory virus epidemics and pandemics will follow .Sng001 will be required . Roche had a stockpile for swine flu worth millions that didn't work well ?

For Oil
snippet Oxford Uni research might confirm the short vaccine protective antibody response ?
in this cohort of working-age healthcare workers, antibody levels rose to a peak at 24 days after the first positive PCR test, before beginning to fall. Those tested had lost their positive antibody result after an average of 137 days. (20weeks approx)

I see they have an ADE (antibody dependant Enhancement ) prevention fraction in Mabs treatment . This also a problem in with vaccines .I do not know if its a potential prob with our treatment? Joey ?

Do not forget we are a broad spectrum antiviral Mabs struggle against mutations according to Fauci

good point imburn but the Germans got their comeuppance after they starved desperate Italy of vital PPE

AZ have a vaccine and an antibody therapeutic if successful they probably done their home work. Which do you think will be the most profitable vaccine or therapeutic and factor in the competition like SNG on a global scale ?

Don't think AZ would doing a large Trial if they did not think there was no market for their therapeutic product

Manchester Proff talking about the AZ Antibody Trial...... I should have said ..........

Manchester Proff Talking about Antibody caught the jist of it up to 100,000 vulnerable may need treatments who would not benefit from vaccination

The number of times I have heard that con Remdes mentioned by politicians and health professionals with no regard for SNG sickening . Nevertheless keeps us in pole position as a antiviral

Pmjh do you know more about this trial-thanks
Eight patients took part in the national trial, at Oxford’s John Radcliffe Hospital.

Professor Nick Lemoine, Medical Director of the NIHR Clinical Research Network said: “Results from early phase research into Synairgen’s respiratory treatment, SNG001, show this drug’s potential as an effective therapeutic option for Covid-19. As an urgent public health study, the phase 3 trial will now be prioritised for fast track set-up and delivery across the NHS – on a much larger scale. This will give many more UK patients the opportunity to take part and potentially benefit from this exciting new treatment, as we move into the second wave
I like the part where UK patients will potentially benefit bring it on quick!